News:
R.I.P to the great Charlie Kirk!
- Welcome to THeBlueCashew.
Recent posts
#71
Politics / Re: DHS fires back after Dem l...
Last post by Prof Emeritus at Fawk U - Today at 08:39:41 AMStrange how the Dems can't ever show a video of what they claim happened. Leftist idiots usually pull out their phones for any confrontation, but not in this case. I wonder why.
#72
Art, Hard Rock & Harmony / Re: Random Videos From Around ...
Last post by Prof Emeritus at Fawk U - Today at 08:35:54 AMQuote from: Shen Li on December 07, 2025, 10:07:12 PM
Funny, but AI generated.
#73
The Guest Nest / Re: You must insult the person...
Last post by Prof Emeritus at Fawk U - Today at 08:32:57 AMShe didn't know why people were making such a big deal about her wearing a one piece bathing suit with a thong at the beach.
Except that she wore it backwards.
Except that she wore it backwards.
#74
The U.S. Department of Transportation said it may withhold up to $30.4 million in federal highway funds from Minnesota for improperly issuing commercial driver licenses to non-U.S. residents.
The department gave Minnesota Gov. Tim Walz 30 days to revoke the licenses and come into compliance after a federal audit.
The department gave Minnesota Gov. Tim Walz 30 days to revoke the licenses and come into compliance after a federal audit.
#75
Quote from: Shen Li on December 07, 2025, 11:38:19 PMThis is red meat for Skinz.This is his second favourite topic. Flat earth is number one.
#76
Much like in Canada, health care is eating up a growing share of government budgets.
Medicare is the second-largest program in the federal budget, topping $1 trillion last year. In 2023, it accounted for 14% of federal spending — a share projected to reach 18% by 2032. After years of ballooning costs, something is finally being done to slow the growth. A new Medicare pilot program, the Wasteful and Inappropriate Service Reduction model, borrows a successful private-sector tool: prior authorization. And that's good news.
Medicare Part B premiums now sit at $185 per month — up 28% from five years ago and a staggering 76% since 2015. Last year, 12% of the 61 million Americans enrolled in Part B spent more than a tenth of their annual income on premiums. That burden is unsustainable.
WISeR, set to launch in Ohio, Texas, Washington, New Jersey, Arizona, and Oklahoma, will require prior approval for a short list of "low-value" services — procedures that research shows are frequently overused, costly, and sometimes harmful.
To some, the idea of Medicare reviewing certain treatments before covering them may sound like red tape. But when done correctly, prior authorization is not a barrier. It is a guardrail — one that protects patients, improves quality, and helps ensure that both tax dollars and premiums are spent appropriately.
Prior authorization directly targets some of the most persistent problems in health care. Medicare spends billions each year on low-value services. A 2023 study identified just 47 such services that together cost Medicare more than $4 billion annually. Those are taxpayer dollars that could be put to better use.
The private insurance market shows the same pattern: unnecessary imaging, avoidable specialist referrals, and brand-name drugs chosen over generics all contribute to rising premiums. Prior authorization, when used properly, reins in this waste by ensuring coverage lines up with medical necessity and evidence-based best practices. Research from the University of Chicago shows that Medicare's prior authorization rules for prescription drugs generate net savings even after administrative costs.
Consider one striking example. Medicare Part B covers wound-care products known as skin substitutes. But an Office of Inspector General report found that expenditures on these products skyrocketed over the past two years to more than $10 billion annually. Meanwhile, Medicare Advantage plans — which rely heavily on prior authorization — spent only a fraction of that amount for the same treatments.
Medicare is the second-largest program in the federal budget, topping $1 trillion last year. In 2023, it accounted for 14% of federal spending — a share projected to reach 18% by 2032. After years of ballooning costs, something is finally being done to slow the growth. A new Medicare pilot program, the Wasteful and Inappropriate Service Reduction model, borrows a successful private-sector tool: prior authorization. And that's good news.
Medicare Part B premiums now sit at $185 per month — up 28% from five years ago and a staggering 76% since 2015. Last year, 12% of the 61 million Americans enrolled in Part B spent more than a tenth of their annual income on premiums. That burden is unsustainable.
WISeR, set to launch in Ohio, Texas, Washington, New Jersey, Arizona, and Oklahoma, will require prior approval for a short list of "low-value" services — procedures that research shows are frequently overused, costly, and sometimes harmful.
To some, the idea of Medicare reviewing certain treatments before covering them may sound like red tape. But when done correctly, prior authorization is not a barrier. It is a guardrail — one that protects patients, improves quality, and helps ensure that both tax dollars and premiums are spent appropriately.
Prior authorization directly targets some of the most persistent problems in health care. Medicare spends billions each year on low-value services. A 2023 study identified just 47 such services that together cost Medicare more than $4 billion annually. Those are taxpayer dollars that could be put to better use.
The private insurance market shows the same pattern: unnecessary imaging, avoidable specialist referrals, and brand-name drugs chosen over generics all contribute to rising premiums. Prior authorization, when used properly, reins in this waste by ensuring coverage lines up with medical necessity and evidence-based best practices. Research from the University of Chicago shows that Medicare's prior authorization rules for prescription drugs generate net savings even after administrative costs.
Consider one striking example. Medicare Part B covers wound-care products known as skin substitutes. But an Office of Inspector General report found that expenditures on these products skyrocketed over the past two years to more than $10 billion annually. Meanwhile, Medicare Advantage plans — which rely heavily on prior authorization — spent only a fraction of that amount for the same treatments.
#77
Quote from: J E B Stuart on December 07, 2025, 11:45:30 PMA boxing deer.
Amen.
#78
Quote from: deport_liberals on Today at 04:19:33 AMIt reminds me of millions of people.
https://nypost.com/2025/12/07/media/rosie-odonnells-therapist-told-her-to-detach-from-trump-for-two-days-she-lasted-only-hours/
#79
Quote from: Shen Li on December 07, 2025, 10:21:52 PMI saw the original BF. It was a lively forum. Good posters, interesting topics and plenty of LOLs.The elderly ten people that post on that forum are hardly representative of Caucasians anywhere.
BF 2.0 on the other hand is an example of why I support a mass cull of North America's white population.
#80
